RxDoctor Payments Data

Whitney Shafer, NP

Nurse Practitioner · Warren, INNPI 1598173056

Payments from drug & device makers

$629in general payments, 2019–2025

Across 37 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$170
  • Novo Nordisk$166
  • Lilly USA, LLC$103
  • Exact Sciences$66
  • AstraZeneca$49
  • Astellas Pharma US Inc$32
  • plus $43 from 2 others

What the payments were for

  • Food & beverage$629100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$629 in reported general payments places this provider in the 65th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$33,329
Medicare patients
129
Services billed
490

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$97,120
MounjaroTirzepatide17$28,116
JardianceEmpagliflozin16$27,460
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$22,671
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,818
Ventolin HfaAlbuterol Sulfate14$2,133
Celecoxib19$2,073
Gabapentin65$1,724
Albuterol Sulfate HfaAlbuterol Sulfate77$1,596
Pregabalin19$1,582
Levothyroxine Sodium122$1,374
SynthroidLevothyroxine Sodium20$1,223
Pantoprazole Sodium84$1,193
Famotidine44$1,006
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide13$956

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$166$97,12060 claims
Lilly USA, LLCMounjaro$103$28,11617 claims
AbbVieSynthroid$170$1,22320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Warren

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →